Other
Supplementary Table S1 from SALVO: Single Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma
Abstract
Authors
Kottschade LA; Pond GR; Olszanski AJ; Zakharia Y; Domingo-Musibay E; Hauke RJ; Curti BD; Schober S; Milhem MM; Block MS
Publication Date
September 16, 2024
DOI
10.1158/1078-0432.27030649.v1